Evidence map›Paper›PMID 31028692›Full record

ArticleJournal of neurovirology2019

HIV infection and age effects on striatal structure are additive.

Erin E O'Connor, Timothy Zeffiro, Oscar L Lopez, James T Becker, Thomas Zeffiro

Open access · greenAbstract read
In one paragraph

Article in Journal of neurovirology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Differential Effects of AIDS and Chronic Human Immunodeficiency Virus Infection on Gray Matter Volume.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  10. Greater Sensorimotor Deficits and Abnormally Lower Globus Pallidus Fractional Anisotropy in HIV+ Women than in HIV+ Men.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Erin E O'ConnorDepartment of Diagnostic Radiology and Nuclear Medicine, University of Maryland, Baltimore, MD, USA. erin.oconnor@umm.edu.
Timothy ZeffiroJohns Hopkins School of Public Health, Baltimore, MD, USA.
Oscar L LopezDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
James T BeckerDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
Thomas ZeffiroDepartment of Diagnostic Radiology and Nuclear Medicine, University of Maryland, Baltimore, MD, USA.
University of Maryland, Baltimore · USUniversity of Pittsburgh · USJohns Hopkins University · US

Funding

Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2020 to 2026
$29.4M
Cardiovascular and HIV/AIDS Effects on Brain Structure/Function and CognitionR01AG034852 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 2010 to 2020
$9.2M
Age Moderates HIV-Related CNS DysfunctionR01AG021431 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 2002 to 2005
$1.4M
Magnetoencephalography as a Biomarker for HIV-Associated Neurocognitive DisorderR21MH098745 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 2012 to 2013
$398k
Cerebral Blood Flow in HIV/AIDS and Drug Abuse Detected by CASL MRIR03DA025986 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 2008 to 2009
$303k
Pilot Study of the Utility of MEG Imaging in HIV/AIDSR03MH081721 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 2008 to 2009
$152k
NIA NIH HHS P30 AG066468NIA NIH HHS R01 AG021431NIA NIH HHS R01AG021431NIA NIH HHS R01 AG034852NIA NIH HHS R01 AG034852-08S1NIDA NIH HHS R03 DA025986NIH HHS R03DA025986NIH HHS R03MH081721NIH HHS R21MH098745NIMH NIH HHS R03 MH081721NIMH NIH HHS R21 MH098745
6 · The paper itself

Abstract

The age of the HIV-infected population is increasing. Although many studies document gray matter volume (GMV) changes following HIV infection, GMV also declines with age. Findings have been inconsistent concerning interactions between HIV infection and age on brain structure. Effects of age, substance use, and inadequate viral suppression may confound identification of GMV serostatus effects using quantitative structural measures. In a cross-sectional study of HIV infection, including 97 seropositive and 84 seronegative, demographically matched participants, ages 30-70, we examined serostatus and age effects on GMV and neuropsychological measures. Ninety-eight percent of seropositive participants were currently treated with anti-retroviral therapies and all were virally suppressed. Gray, white, and CSF volumes were estimated using high-resolution T1-weighted MRI. Linear regression modeled effects of serostatus, age, education, comorbidities, and magnetic field strength on brain structure, using both a priori regions and voxel-based morphometry. Although seropositive participants exhibited significant bilateral decreases in striatal GMV, no serostatus effects were detected in the thalamus, hippocampus, or cerebellum. Age was associated with cortical, striatal, thalamic, hippocampal, and cerebellar GMV reductions. Effects of age and serostatus on striatal GMV were additive. Although no main effects of serostatus on neuropsychological performance were observed, serostatus moderated the relationship between pegboard performance and striatal volume. Both HIV infection and age were associated with reduced striatal volume. The lack of interaction of these two predictors suggests that HIV infection is associated with premature, but not accelerated, brain age. In serostatus groups matched on demographic and clinical variables, there were no observed differences in neuropsychological performance. Striatal GMV measures may be promising biomarker for use in studies of treated HIV infection.

Indexed as

AdultAgedAge FactorsAgingAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBrain MappingCase-Control StudiesCorpus StriatumFemaleGray MatterHippocampusHIV InfectionsHumansMagnetic Resonance ImagingMaleAnti-HIV AgentsAIDSHepatitis CMorphometryMRIVBM

Identifiers

PMID31028692
PMCPMC10488234
OpenAlexW2940723677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.